155 related articles for article (PubMed ID: 17909030)
1. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas.
Qi CF; Xiang S; Shin MS; Hao X; Lee CH; Zhou JX; Torrey TA; Hartley JW; Fredrickson TN; Morse HC
Leuk Res; 2006 Feb; 30(2):153-63. PubMed ID: 16122798
[TBL] [Abstract][Full Text] [Related]
3. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
Baldassarre G; Belletti B; Nicoloso MS; Schiappacassi M; Vecchione A; Spessotto P; Morrione A; Canzonieri V; Colombatti A
Cancer Cell; 2005 Jan; 7(1):51-63. PubMed ID: 15652749
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL
Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of p27Kip1 promotes chemical mouse liver tumorigenesis in the resistant strain C57BL/6J.
Sun D; Ren H; Oertel M; Sellers RS; Shafritz DA; Zhu L
Mol Carcinog; 2008 Jan; 47(1):47-55. PubMed ID: 17620307
[TBL] [Abstract][Full Text] [Related]
7. p27Kip1 localization depends on the tumor suppressor protein tuberin.
Rosner M; Freilinger A; Hanneder M; Fujita N; Lubec G; Tsuruo T; Hengstschläger M
Hum Mol Genet; 2007 Jul; 16(13):1541-56. PubMed ID: 17470459
[TBL] [Abstract][Full Text] [Related]
8. The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Polyak K
Cancer Cell; 2006 Nov; 10(5):352-4. PubMed ID: 17097557
[TBL] [Abstract][Full Text] [Related]
9. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
Serres MP; Zlotek-Zlotkiewicz E; Concha C; Gurian-West M; Daburon V; Roberts JM; Besson A
Oncogene; 2011 Jun; 30(25):2846-58. PubMed ID: 21317921
[TBL] [Abstract][Full Text] [Related]
11. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
12. How to decrease p27Kip1 levels during tumor development.
Koff A
Cancer Cell; 2006 Feb; 9(2):75-6. PubMed ID: 16473274
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
Sun X; Zhang HW; Zhang ZR
J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin.
Akalu A; Roth JM; Caunt M; Policarpio D; Liebes L; Brooks PC
Cancer Res; 2007 May; 67(9):4353-63. PubMed ID: 17483349
[TBL] [Abstract][Full Text] [Related]
15. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
[TBL] [Abstract][Full Text] [Related]
16. Loss of p27Kip1 enhances tumor progression in chronic hepatocyte injury-induced liver tumorigenesis with widely ranging effects on Cdk2 or Cdc2 activation.
Sun D; Ren H; Oertel M; Sellers RS; Zhu L
Carcinogenesis; 2007 Sep; 28(9):1859-66. PubMed ID: 17434927
[TBL] [Abstract][Full Text] [Related]
17. [p27Kip1: tumor suppressor and oncogene?].
Besson A
Med Sci (Paris); 2007 Dec; 23(12):1089-91. PubMed ID: 18154709
[No Abstract] [Full Text] [Related]
18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
19. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
Chu IM; Hengst L; Slingerland JM
Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.
Kuźbicki L; Aładowicz E; Chwirot BW
Melanoma Res; 2006 Oct; 16(5):435-44. PubMed ID: 17013093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
